Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|November 30, 2019
Prexasertib (LY2606368) reduces clonogenic survival by inducing apoptosis in primary patient-derived osteosarcoma cells and synergizes with cisplatin and talazoparibChristopher L Heidler, Eva K Roth, Markus Thiemann, et al.
International Journal of Cancer|May 12, 2017
Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcomaJan Smida, Hongen Xu, Yanping Zhang, et al.
British Journal of Cancer|August 7, 2015
Target gene mutational pattern in Lynch syndrome colorectal carcinomas according to tumour location and germline mutationManuela Pinheiro, Carla Pinto, Ana Peixoto, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 8, 2015
GNAS mutations are not detected in parosteal and low-grade central osteosarcomasCarolina Salinas-Souza, Carlos De Andrea, Michel Bihl, et al.
Journal of Medical Genetics|March 18, 2020
Germline RET variants underlie a subset of paediatric osteosarcomaMichal Kovac, Connor Woolley, Sebastian Ribi, et al.
Hepatology (Baltimore, Md.)|October 12, 2013
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patientsLuca Quagliata, Matthias S Matter, Salvatore Piscuoglio, et al.
The Journal of Pathology|December 15, 2018
Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of boneDaniel Baumhoer, Michal Kovac, Jan Sperveslage, et al.
The Journal of Pathology|November 27, 2023
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathwayKarim H Saba, Valeria Difilippo, Michal Kovac, et al.
The Journal of Pathology. Clinical Research|June 17, 2020
Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastomaKarim H Saba, Louise Cornmark, Jakob Hofvander, et al.
Nature Communications|April 6, 2016
Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapyJohn M Findlay, Francesc Castro-Giner, Seiko Makino, et al.
Pageof 4